» Articles » PMID: 22743190

Adiposity Facilitates Increased Strength Capacity in Heart Failure Patients with Reduced Ejection Fraction

Overview
Journal Int J Cardiol
Publisher Elsevier
Date 2012 Jun 30
PMID 22743190
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Obesity is associated with relatively improved prognosis among heart failure (HF) patients. Mechanisms explaining this so-called "obesity paradox" have been unclear. We hypothesized that increased adiposity may contribute to increased strength capacity, and may thereby facilitate clinical benefits.

Methods And Results: In a controlled, cross-sectional study, adults aged ≥ 50 years with HF with reduced ejection fraction (HFREF) (LVEF ≤ 40%) were compared to age matched controls. Body composition was determined by dual-energy X-ray absorptiometry (DXA). Aerobic (cardiopulmonary exercise testing), maximum strength (one repetition maximum [1RM]), and power (submaximal resistance/time) were assessed. 70 adults (31 HFREF, 39 controls; mean age 66.2 ± 9.6 years) were studied. Peak oxygen consumption (VO2) (15.4 ± 4.2 vs. 23.4 ± 6.6 ml O2 · kg(-1) · min(-1), p<0.0001), 1RM (154.8 ± 52.0 vs. 195.3 ± 56.8 kg, p<0.01) and power (226.4 ± 99.2 vs. 313.3 ± 130.6, p<0.01) were lower in HFREF vs. controls. 1 RM correlated with total fat (r=0.56, p<0.01), leg fat (r=0.45, p<0.05) and arm fat (r=0.39, p<0.05) in HFREF. Moreover, among HFREF patients with a high (≥ 30 kg/m(2)) body mass index (BMI), 1RM and fat mass were significantly greater than those with lower (<30 kg/m(2)) BMIs. Correlations between 1 RM and total fat (r=0.65, p<0.05) and leg fat (r=0.64, p<0.05) were particularly notable in the high BMI subgroup.

Conclusion: Increased adiposity correlates with relatively greater strength in HFREF patients which may explain some of the clinical benefits that result from obesity.

Citing Articles

Comparison of the Changes in Visceral Adipose Tissue After Lobectomy and Segmentectomy for Patients With Early-Stage Lung Cancer.

Isaka T, Nagashima T, Washimi K, Saito H, Narimatsu H, Shigefuku S J Cachexia Sarcopenia Muscle. 2025; 16(2):e13751.

PMID: 40035113 PMC: 11876859. DOI: 10.1002/jcsm.13751.


Impact of whole-body and skeletal muscle composition on peak oxygen uptake in heart failure: a systematic review and meta-analysis.

Schmid V, Foulkes S, Walesiak D, Wang J, Tomczak C, Tucker W Eur Heart J Open. 2024; 4(5):oeae082.

PMID: 39464232 PMC: 11505452. DOI: 10.1093/ehjopen/oeae082.


Body Mass Index and Mortality.

Yoo H J Obes Metab Syndr. 2019; 26(1):3-9.

PMID: 31089487 PMC: 6484934. DOI: 10.7570/jomes.2017.26.1.3.


Bioelectrical impedance analysis of body composition and survival in patients with heart failure.

Thomas E, Gupta P, Fonarow G, Horwich T Clin Cardiol. 2018; 42(1):129-135.

PMID: 30447075 PMC: 6436517. DOI: 10.1002/clc.23118.


Exercise capacity, physical activity, and morbidity.

Brunjes D, Kennel P, Schulze P Heart Fail Rev. 2017; 22(2):133-139.

PMID: 28091824 PMC: 5352495. DOI: 10.1007/s10741-016-9592-1.


References
1.
Anker S, von Haehling S . The obesity paradox in heart failure: accepting reality and making rational decisions. Clin Pharmacol Ther. 2011; 90(1):188-90. DOI: 10.1038/clpt.2011.72. View

2.
Kistorp C, Faber J, Galatius S, Gustafsson F, Frystyk J, Flyvbjerg A . Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation. 2005; 112(12):1756-62. DOI: 10.1161/CIRCULATIONAHA.104.530972. View

3.
Lavie C, Milani R, Ventura H, Romero-Corral A . Body composition and heart failure prevalence and prognosis: getting to the fat of the matter in the "obesity paradox". Mayo Clin Proc. 2010; 85(7):605-8. PMC: 2894715. DOI: 10.4065/mcp.2010.0333. View

4.
Romero-Corral A, Montori V, Somers V, Korinek J, Thomas R, Allison T . Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet. 2006; 368(9536):666-78. DOI: 10.1016/S0140-6736(06)69251-9. View

5.
Rauchhaus M, Koloczek V, Volk H, Kemp M, Niebauer J, Francis D . Inflammatory cytokines and the possible immunological role for lipoproteins in chronic heart failure. Int J Cardiol. 2000; 76(2-3):125-33. DOI: 10.1016/s0167-5273(00)00224-2. View